CJ Wheeler, KL Black, G Liu, H Ying, JS Yu, W Zhang, PK Lee. (2003) " Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality. " J Immunol 171. 4927-33 PMID: 14568975 | Abstract and Keywords
P Zajac, D Oertli, W Marti, M Adamina, M Bolli, U Guller, C Noppen, E Padovan, E Schultz-Thater, M Heberer, G Spagnoli. (2003) " Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients. " Hum Gene Ther 14. 1497-510 PMID: 14577912 DOI: 10.1089/104303403322495016 | Abstract and Keywords
LH Butterfield, A Ribas, VB Dissette, Y Lee, JQ Yang, P De la Rocha, SD Duran, J Hernandez, E Seja, DM Potter, WH McBride, R Finn, JA Glaspy, JS Economou. (2006) " A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. " Clin Cancer Res 12. 2817-25 PMID: 16675576 DOI: 10.1158/1078-0432.CCR-05-2856 | Abstract and Keywords
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, AH Mintz, JA Engh, DL Bartlett, CK Brown, H Zeh, MP Holtzman, TA Reinhart, TL Whiteside, LH Butterfield, RL Hamilton, DM Potter, IF Pollack, AM Salazar, FS Lieberman. (2010) " Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With {alpha}-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma. " J Clin Oncol 29. 330-6 PMID: 21149657 DOI: 10.1200/JCO.2010.30.7744 | Abstract and Keywords
OE Rahma, E Ashtar, M Czystowska, ME Szajnik, E Wieckowski, S Bernstein, VE Herrin, MA Shams, SM Steinberg, M Merino, W Gooding, C Visus, AB Deleo, JK Wolf, JG Bell, JA Berzofsky, TL Whiteside, SN Khleif. (2011) " A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. " Cancer Immunol Immunother 61. 373-84 PMID: 21927947 DOI: 10.1007/s00262-011-1100-9 | Abstract and Keywords